Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12111 | 867 | 45.3 | 83% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LYMPHOTACTIN | Author keyword | 7 | 38% | 2% | 14 |
2 | CTAP III | Author keyword | 6 | 80% | 0% | 4 |
3 | CHEMOKINE STRUCTURE | Author keyword | 3 | 100% | 0% | 3 |
4 | PLATELET FACTOR 4 | Author keyword | 3 | 11% | 3% | 24 |
5 | XCL1 | Author keyword | 2 | 44% | 0% | 4 |
6 | CXCR3B | Author keyword | 2 | 67% | 0% | 2 |
7 | PF4 | Author keyword | 2 | 19% | 1% | 10 |
8 | MOL MECH ANGIOGENESIS | Address | 2 | 50% | 0% | 3 |
9 | PF 4 | Author keyword | 2 | 50% | 0% | 3 |
10 | CHEMOKINE BINDING PROTEIN | Author keyword | 2 | 40% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LYMPHOTACTIN | 7 | 38% | 2% | 14 | Search LYMPHOTACTIN | Search LYMPHOTACTIN |
2 | CTAP III | 6 | 80% | 0% | 4 | Search CTAP+III | Search CTAP+III |
3 | CHEMOKINE STRUCTURE | 3 | 100% | 0% | 3 | Search CHEMOKINE+STRUCTURE | Search CHEMOKINE+STRUCTURE |
4 | PLATELET FACTOR 4 | 3 | 11% | 3% | 24 | Search PLATELET+FACTOR+4 | Search PLATELET+FACTOR+4 |
5 | XCL1 | 2 | 44% | 0% | 4 | Search XCL1 | Search XCL1 |
6 | CXCR3B | 2 | 67% | 0% | 2 | Search CXCR3B | Search CXCR3B |
7 | PF4 | 2 | 19% | 1% | 10 | Search PF4 | Search PF4 |
8 | PF 4 | 2 | 50% | 0% | 3 | Search PF+4 | Search PF+4 |
9 | CHEMOKINE BINDING PROTEIN | 2 | 40% | 0% | 4 | Search CHEMOKINE+BINDING+PROTEIN | Search CHEMOKINE+BINDING+PROTEIN |
10 | CXCL4 | 2 | 27% | 1% | 6 | Search CXCL4 | Search CXCL4 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MONOMERIC INTERLEUKIN 8 | 45 | 90% | 2% | 19 |
2 | GLYCOSAMINOGLYCAN BINDING | 37 | 46% | 7% | 60 |
3 | FACTOR IV | 28 | 36% | 7% | 64 |
4 | CHEMOKINE PLATELET FACTOR 4 | 24 | 91% | 1% | 10 |
5 | CTAP III | 19 | 71% | 2% | 15 |
6 | PLATELET FACTOR IV | 18 | 23% | 8% | 68 |
7 | PLATELET BASIC PROTEIN | 18 | 53% | 3% | 23 |
8 | MCP 1 RECEPTOR | 16 | 54% | 2% | 21 |
9 | GROWTH STIMULATING ACTIVITY | 14 | 53% | 2% | 19 |
10 | C CHEMOKINE LYMPHOTACTIN | 13 | 80% | 1% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Chemokine oligomerization and interactions with receptors and glycosaminoglycans: The role of structural dynamics in function | 2011 | 45 | 86 | 67% |
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies | 2015 | 3 | 104 | 43% |
Chemokine: Receptor structure, interactions, and antagonism | 2007 | 341 | 203 | 23% |
Structure junction, and inhibition of chemokines | 2002 | 305 | 169 | 33% |
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer | 2011 | 26 | 161 | 53% |
Regulation of protein function by glycosaminoglycans - as exemplified by chemokines | 2005 | 244 | 111 | 31% |
Chemokines | 1997 | 1983 | 265 | 14% |
Platelet Chemokines in Vascular Disease | 2008 | 88 | 82 | 39% |
Platelet factor-4 (CXCL4/PF-4): An angiostatic chemokine for cancer therapy | 2013 | 5 | 64 | 78% |
Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology | 2013 | 6 | 78 | 71% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL MECH ANGIOGENESIS | 2 | 50% | 0.3% | 3 |
2 | GROWTH TOR CELL DIFFERENTIAT | 2 | 43% | 0.3% | 3 |
3 | MED CHEM MED PHARMACOL | 1 | 100% | 0.2% | 2 |
4 | MOL BIOPHYS MED SCIENTIST TRAINING PROGRAM | 1 | 100% | 0.2% | 2 |
5 | HERITAGE MED 713 | 1 | 29% | 0.5% | 4 |
6 | BIOPHYS RUMENTAT IL | 1 | 33% | 0.3% | 3 |
7 | PL IMMUNOBIOL GRP | 1 | 24% | 0.5% | 4 |
8 | INSERM E0113 | 1 | 40% | 0.2% | 2 |
9 | PROT CHEM BIOPHYS | 1 | 40% | 0.2% | 2 |
10 | HIGH FIELD NMR IL | 1 | 33% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000228035 | BB 10010//CK BETA 8//STEM CELL INHIBITOR |
2 | 0.0000213704 | CXCR2//CXCR1//G31P |
3 | 0.0000170890 | EOTAXIN//CCR3//RANTES |
4 | 0.0000162305 | CCR2 ANTAGONIST//CCR2//CCR2 ANTAGONISTS |
5 | 0.0000151784 | DUFFY BLOOD GROUP//DARC//DUFFY ANTIGEN |
6 | 0.0000137501 | CXCR3//CXCL10//CXCL9 |
7 | 0.0000113290 | MONOCYTE CHEMOATTRACTANT PROTEIN 1//MCP 1 POLYMORPHISM//REGULATED UPON ACTIVATION |
8 | 0.0000095828 | TYROSYLPROTEIN SULFOTRANSFERASE//TYROSINE SULFATION//PROTEIN SULFATION |
9 | 0.0000086333 | PLATELET PROTEOME//EFS AUVERGNE LOIRE//SECT CARDIOIMMUNOL |
10 | 0.0000084855 | CXCR4//CXCR7//CXCL12 |